![](/img/cover-not-exists.png)
Treatment of ALK-rearranged non-small-cell lung cancer with brigatinib as second or later lines
Hochmair, Maximilian, Weinlinger, Christoph, Schwab, Sophia, Naber, Jakob, Setinek, Ulrike, Krenbek, Dagmar, Urban, Matthias H., Fabikan, Hannah, Watzka, Stefan, Koger, Renate, Fazekas, Andreas, BitteVolume:
30
Journal:
Anti-Cancer Drugs
DOI:
10.1097/cad.0000000000000787
Date:
August, 2019
File:
PDF, 239 KB
2019